147 related articles for article (PubMed ID: 2170973)
41. Paragangliomas of the head and neck: immunohistochemical neuroendocrine and intermediate filament typing.
Johnson TL; Zarbo RJ; Lloyd RV; Crissman JD
Mod Pathol; 1988 May; 1(3):216-23. PubMed ID: 2467285
[TBL] [Abstract][Full Text] [Related]
42. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
[TBL] [Abstract][Full Text] [Related]
43. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
Shia J; Tang LH; Weiser MR; Brenner B; Adsay NV; Stelow EB; Saltz LB; Qin J; Landmann R; Leonard GD; Dhall D; Temple L; Guillem JG; Paty PB; Kelsen D; Wong WD; Klimstra DS
Am J Surg Pathol; 2008 May; 32(5):719-31. PubMed ID: 18360283
[TBL] [Abstract][Full Text] [Related]
44. The biological implications of bronchial tumors.
Warren WH; Memoli VA; Kittle CF; Jensik RJ; Faber LP; Gould VE
J Thorac Cardiovasc Surg; 1984 Feb; 87(2):274-82. PubMed ID: 6319828
[TBL] [Abstract][Full Text] [Related]
45. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
Liu Y; Sturgis CD; Grzybicki DM; Jasnosz KM; Olson PR; Tong M; Dabbs DD; Raab SS; Silverman JF
Mod Pathol; 2001 Sep; 14(9):880-5. PubMed ID: 11557784
[TBL] [Abstract][Full Text] [Related]
46. Reevaluation and reclassification of resected lung carcinomas originally diagnosed as squamous cell carcinoma using immunohistochemical analysis.
Kadota K; Nitadori J; Rekhtman N; Jones DR; Adusumilli PS; Travis WD
Am J Surg Pathol; 2015 Sep; 39(9):1170-80. PubMed ID: 25871623
[TBL] [Abstract][Full Text] [Related]
47. Contribution of immunohistochemistry in the differential diagnosis of non-small cell lung carcinomas on small biopsy samples.
Stojsic J; Jovanic I; Markovic J; Gajic M
J BUON; 2013; 18(1):176-87. PubMed ID: 23613404
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical evaluation of neuroendocrine cells and neoplasms of the lung.
Gould VE; Lee I; Warren WH
Pathol Res Pract; 1988 Apr; 183(2):200-13. PubMed ID: 3290868
[TBL] [Abstract][Full Text] [Related]
49. Correlation between neovascularisation and neuroendocrine differentiation in prostatic carcinoma.
Grobholz R; Bohrer MH; Siegsmund M; Jünemann KP; Bleyl U; Woenckhaus M
Pathol Res Pract; 2000; 196(5):277-84. PubMed ID: 10834383
[TBL] [Abstract][Full Text] [Related]
50. Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours.
Sundaresan V; Reeve JG; Stenning S; Stewart S; Bleehen NM
Br J Cancer; 1991 Aug; 64(2):333-8. PubMed ID: 1654075
[TBL] [Abstract][Full Text] [Related]
51. Cytologic and histopathologic diagnosis in bronchopulmonary squamous cell carcinoma.
Drăgan AM; Roşca E; Muţiu G
Rom J Morphol Embryol; 2011; 52(1 Suppl):395-8. PubMed ID: 21424081
[TBL] [Abstract][Full Text] [Related]
52. [2014 classification of lung carcinomas: latest entities and clinical implications. Case 1: Poorly differentiated non small cell lung carcinoma: interpretation of small biopsy specimens].
Vignaud JM
Ann Pathol; 2013 Oct; 33(5):306-10. PubMed ID: 24238239
[No Abstract] [Full Text] [Related]
53. Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples.
Kriegsmann K; Zgorzelski C; Muley T; Christopoulos P; Thomas M; Winter H; Eichhorn M; Eichhorn F; von Winterfeld M; Herpel E; Goeppert B; Stenzinger A; Herth FJF; Warth A; Kriegsmann M
BMC Cancer; 2021 May; 21(1):486. PubMed ID: 33933015
[TBL] [Abstract][Full Text] [Related]
54. Immunohistochemical and ultrastructural study of mixed small cell/large cell carcinoma of the lung. Expression of Sialyl LeX-i antigens and scarcity of neuroendocrine characteristics.
Yokose T; Asami H; Ito Y
Acta Pathol Jpn; 1991 Jul; 41(7):540-51. PubMed ID: 1661556
[TBL] [Abstract][Full Text] [Related]
55. The value of neuroendocrine markers in non-small cell lung cancer: a comparative immunohistopathologic study.
Kiriakogiani-Psaropoulou P; Malamou-Mitsi V; Martinopoulou U; Legaki S; Tamvakis N; Vrettou E; Fountzilas G; Skarlos D; Kosmidis P; Pavlidis N
Lung Cancer; 1994 Dec; 11(5-6):353-64. PubMed ID: 7535640
[TBL] [Abstract][Full Text] [Related]
56. [Cytomorphologic characteristics of poorly differentiated forms of lung cancer].
Bolgova LS; Tuganova TN
Lab Delo; 1991; (12):32-5. PubMed ID: 1724485
[TBL] [Abstract][Full Text] [Related]
57. The respiratory epithelium. V. Histogenesis of lung carcinomas in the human.
McDowell EM; McLaughlin JS; Merenyl DK; Kieffer RF; Harris CC; Trump BF
J Natl Cancer Inst; 1978 Aug; 61(2):587-606. PubMed ID: 210296
[TBL] [Abstract][Full Text] [Related]
58. Involucrin in well-differentiated adenocarcinoma of the lung. Comparison with adenocarcinomas of different organs.
Ando K; Kikuchi M; Eimoto T; Shirakusa T
Pathol Res Pract; 1991 Jan; 187(1):50-4. PubMed ID: 2027822
[TBL] [Abstract][Full Text] [Related]
59. [Colon adenocarcinoma with neuroendocrine and squamous cell differentiation. A case report].
Santos GC; Zucoloto S; Coelho KI; Schmitt FC
Arq Gastroenterol; 1992; 29(2):62-5. PubMed ID: 1307207
[TBL] [Abstract][Full Text] [Related]
60. Large cell carcinoma of the lung with neuroendocrine differentiation. A comparison with large cell "undifferentiated" pulmonary tumors.
Wick MR; Berg LC; Hertz MI
Am J Clin Pathol; 1992 Jun; 97(6):796-805. PubMed ID: 1317668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
